Overview

Persantin Preceding Elective PCI

Status:
Completed

Trial end date:
2010-02-01

Target enrollment:

Participant gender:

Summary

In this study the investigators will investigate whether a short pretreatment (3-7 days) with dipyridamole 200mg twice daily will protect patients against myocardial injury sustained during an elective dotter operation of the coronary arteries (PCI). The investigators hypothesize that dipyridamole can reduce myocardial injury sustained during elective PCI.

Phase:

Phase 4

Details

Lead Sponsor:

Radboud University

Treatments:

Dipyridamole